Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain.
Signaling proteins are localized and regulated by Src homology 2 domains which recognize phosphotyrosine-containing sequences. Recently, noncanonical ligands have been proposed for Src homology 2 domains including that of Abl and its breakpoint cluster region fusion, which causes chronic myelogenous leukemia. Here, the Abl Src homology 2 domain's binding sites and affinities for phosphotyrosine- and phosphoserine-containing motifs, phosphoinositides as well as a pyridone-based peptidomimetic inhibitor were determined using nuclear magnetic resonance spectroscopy in order to define their roles. The cognate Crk peptide ligand was bound with an affinity of 69 microM and, like the higher affinity peptidomimetic, engages the phosphotyrosine and +3 hydrophobic pockets while putative phosphoserine-containing breakpoint cluster region ligands are ruled out. Surprisingly, phosphatidylinositol 4, 5 bisphosphate interacts with an overlapping site through an electrostatic mechanism that does not appear to involve hydrophobic insertion into micelles. The conserved Arg36 residue in the FLVRES motif is required for both phosphotyrosine binding and for localization to phosphatidylinositol 4, 5 bisphosphate-containing liposomes, while Arg59 in the betaD strand is necessary for the phosphoinositide interaction. Thus the Src homology 2 domain of Abl, a myristoylated and membrane-localized protein, is able to interact directly with phosphoinositides through a multifunctional basic site that overlaps the phosphotyrosine pocket.
Tokonzaba
Etienne
E
Department of Pharmacology, University of Colorado Health Sciences Center,12801 East 17th Avenue, Aurora, CO 80045, USA.
Capelluto
Daniel G S
DG
Kutateladze
Tatiana G
TG
Overduin
Michael
M
D000818:Animals; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D008565:Membrane Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008823:Micelles; D016297:Mutagenesis, Site-Directed; D019814:Myristic Acid / Q000737:chemistry / Q000378:metabolism; D019269:Phosphatidylinositol 4,5-Diphosphate / Q000378:metabolism; D010716:Phosphatidylinositols / Q000737:chemistry / Q000378:metabolism*; D010748:Phosphopeptides / Q000737:chemistry / Q000378:metabolism*; D019000:Phosphotyrosine / Q000737:chemistry / Q000378:metabolism; D016315:Proto-Oncogene Proteins c-abl / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011728:Pyridones / Q000737:chemistry / Q000378:metabolism*; D018909:src Homology Domains / Q000235:genetics
D008024:Ligands; D008565:Membrane Proteins; D008823:Micelles; D019269:Phosphatidylinositol 4,5-Diphosphate; D010716:Phosphatidylinositols; D010748:Phosphopeptides; D011728:Pyridones; D019814:Myristic Acid; D019000:Phosphotyrosine; D016315:Proto-Oncogene Proteins c-abl